JPMorgan Upgrades HB Fuller on 13% EBITDA Growth Forecast
1h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
jpmorganhb-fuller
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
JPMorgan Chase & Co. upgraded its rating on HB Fuller Co. stock to Overweight from Neutral on June 26, 2026, driven by a positive reassessment of the company's earnings potential. The firm's analysts project the specialty adhesives manufacturer will achieve approximately 13% EBITDA growth in the coming fiscal year, citing improved pricing power and stabilizing end-market demand. JPMorgan's own stock traded at $335.12, up 0.29% on the day, as of 07:47 UTC today. The upgrade reflects a significant shift in sentiment for a key player in the industrial supply chain.
This marks the first major rating upgrade for HB Fuller by a bulge-bracket bank since Barclays raised its price target in October 2025. The industrial adhesives sector has faced headwinds over the past 18 months, with the S&P 500 Materials Index declining 4% year-to-date amid concerns over a global manufacturing slowdown. The catalyst for JPMorgan's reassessment appears to be a combination of resilient construction data and a sequential improvement in automotive production volumes, two of HB Fuller's core markets. Stabilizing raw material costs after a period of high volatility have also improved margin visibility for the company, allowing for more accurate earnings projections.
The timing coincides with a broader recalibration of industrial stocks as markets anticipate potential Federal Reserve policy easing in early 2027. Bond yields have retreated from their 2025 highs, with the 10-year Treasury note yielding 4.18%, reducing financing costs for capital-intensive industrial projects. HB Fuller's upgrade suggests analysts see the company as well-positioned to capitalize on an early-cycle industrial recovery, particularly in non-residential construction and durable goods manufacturing. The firm's last earnings report in late May already showed signs of gross margin expansion, which JPMorgan's analysis now confirms is a sustainable trend.
JPMorgan's new $78 price target implies a 15% upside from HB Fuller's previous closing price. The analyst team forecasts EBITDA to reach approximately $650 million for fiscal 2026, up from an estimated $575 million in the prior year. This projected 13% growth rate substantially outpaces the sector median forecast of 7% for specialty chemical peers. HB Fuller's enterprise value to EBITDA multiple of 10.5x now trades at a slight premium to its three-year average of 9.8x, reflecting the improved growth outlook.
| Metric | Pre-Upgrade View | Post-Upgrade View | Change |
|---|---|---|---|
| Rating | Neutral | Overweight | 2 Notches |
| Price Target | $68 | $78 | +14.7% |
| Projected EBITDA Growth | ~8% | ~13% | +5 ppts |
The company's leverage ratio, a key concern during the 2024-2025 rate hike cycle, is projected to fall below 3.0x by the end of fiscal 2026, down from a peak of 3.8x in Q3 2025. This improvement is driven by both EBITDA expansion and deliberate debt reduction from strong operational cash flow. Peer company RPM International Inc. trades at a higher 12.1x EBITDA multiple, suggesting room for HB Fuller's valuation to expand further if it successfully executes on its growth targets. JPMorgan's stock price range for the day was $334.76 to $343.45, showing moderate volatility during the announcement period.
The upgrade has positive implications for the broader industrial adhesives and sealants sector, including companies like RPM International (RPM) and H.B. Fuller's direct competitor, Arkema S.A. (AKE). Suppliers of key raw materials, such as Dow Inc. (DOW) for acrylics and Westlake Chemical (WLK) for vinyl acetate monomers, could see increased demand visibility. The more optimistic outlook suggests analysts anticipate a recovery in industrial production indices, which have been negative in two of the last three quarters. A sustained rebound in HB Fuller's order book would signal strengthening demand across manufacturing supply chains.
The primary risk to this thesis is a reacceleration of inflation in industrial commodities, which could compress the very margins JPMorgan is forecasting to expand. Any delay in the expected Fed easing cycle would also maintain higher financing costs for HB Fuller's customers, potentially dampening capital expenditure and new project starts. Institutional flow data from the previous session showed net buying in materials sector ETFs, with the Materials Select Sector SPDR Fund (XLB) recording $120 million in inflows. This upgrade may reinforce that trend, drawing further institutional attention to overlooked mid-cap industrial names.
Market participants should monitor HB Fuller's Q2 2026 earnings release, scheduled for July 23, 2026, for confirmation of the margin improvement trajectory. The next critical data point for the sector will be the ISM Manufacturing PMI report for June, due July 1, 2026, with analysts expecting a reading of 49.5, just below the expansionary 50.0 threshold. A surprise above 50.0 would likely provide additional support for JPMorgan's upgraded thesis. Key resistance for HB Fuller's stock is seen at the $70 level, a point it has tested but failed to breach convincingly in the past six months.
The Federal Open Market Committee meeting on July 29, 2026, will be scrutinized for any signals regarding the timing of rate cuts, which would lower the cost of capital for HB Fuller's industrial customers. Support for the stock is established at its 200-day moving average near $62, which has held through three separate tests in 2026. A break above the $72 resistance level on heavy volume would technically confirm the bullish reversal implied by the analyst upgrade and could trigger a move toward JPMorgan's $78 target.
HB Fuller has maintained a modest dividend yield of approximately 1.2%, prioritizing debt reduction and organic growth over significant shareholder returns. The upgrade to Overweight, based on strong projected free cash flow, increases the probability of a dividend hike or a special dividend announcement in the next 12 months. The company's payout ratio is a conservative 25%, leaving ample room for increases if EBITDA growth materializes as forecast. JPMorgan's analysis suggests the balance sheet will be sufficiently strong to support enhanced capital returns by early 2027.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.